Barbara E. Murray, MD, FIDSA, is is director of the Division of Infectious Diseases and the Department of Internal Medicine at the University of Texas (UT) Medical School at Houston. She also serves as co-director of the Center for the Study of Emerging and Re-Emerging Pathogens at the UT Health Science Center-Houston.
She previously served as IDSA’s Secretary-Treasurer and on numerous committees and task forces. Currently, she serves on the Editorial Board of The Journal of Infectious Diseases and as a member of IDSA’s Antibiotic Availability Task Force.
Dr. Murray’s research interests include the pathogenesis of E. faecium and of E. faecalis, mechanisms of antibiotic resistance, the molecular epidemiology of antibiotic resistant organisms and diarrheagenic pathogens, and the efficacy of antibiotics against resistant enterococci and staphylococci. She has served in leadership positions in many organizations, including the American Society for Microbiology, the International Society for Infectious Diseases, the American Society for Clinical Investigation, and the National Foundation for Infectious Diseases.
Dr. Murray attended medical school at the University of Texas Southwestern Medical School, did a fellowship in tropical medicine at Louisiana State University, and did her internship, residency and ID fellowship at Massachusetts General Hospital and Harvard Medical School.
Stephen B. Calderwood, MD, FIDSA, is the Morton N. Swartz, MD Academy Professor of Medicine (Microbiology and Immunobiology) at Harvard Medical School, chief of the Division of Infectious Diseases, vice chair, Department of Medicine, and director of Undergraduate Medical Education at Massachusetts General Hospital.
He has played an active role in IDSA, having served on the Board of Directors, Society Awards Committee, Training Program Directors Committee, and Education Committee. He is also currently the co-editor-in-chief for the infectious diseases sections of UpToDate. Dr. Calderwood is a fellow of the American Academy of Microbiology, American College of Physicians, and the American Association for Advancement of Science, and a member of the Association of American Physicians. He is a past president of the Massachusetts Infectious Diseases Society. Dr. Calderwood graduated from Harvard Medical School, and completed his internship, residency, and clinical and research fellowship in infectious diseases at Massachusetts General Hospital.
Johan Bakken, MD, PhD, FIDSA, is a consultant in infectious diseases at St. Luke’s Hospital and a clinical associate professor at the University of Minnesota Medical School Duluth.
Dr. Bakken served as chair of the IDSA State and Regional Societies (SRS) Board. During his involvement with the SRS, he demonstrated the value of the ID clinician and advocated for better compensation for the varied services they provide. He has pioneered outpatient parenteral antimicrobial therapy, fecal biotherapy for C. diff, and evidence-based treatment of Lyme disease, contributing to related IDSA guidelines. Currently, he serves on the IDSA Diagnostics Task Force, which is examining the research, development, approval, manufacture, regulation and uptake of infectious diseases diagnostics.
Dr. Bakken graduated from the University of Washington (UW) School of Medicine in 1972. He completed an internship in internal medicine at the University of California Los Angeles and subsequent residencies in internal medicine at UW and the Lillehammer Regional Hospital in Norway. Dr. Bakken did his fellowship in ID at the University of Oslo, Norway, and completed a two-year postdoctoral fellowship in microbiology at Creighton University, Omaha, Nebraska in 1987.
Penelope H. Dennehy, MD, FIDSA, is professor and vice chair for academic affairs in the Department of Pediatrics at Alpert Medical School of Brown University. She is also director of the Division of Pediatric Infectious Diseases at Hasbro Children’s Hospital and program director of the combined Medicine and Pediatric Infectious Diseases Fellowships at Rhode Island Hospital. Her research interests include viral gastroenteritis and viral respiratory diseas¬es in children; clinical trials of vaccines against rotavirus, influenza, and varicella; epidemiology and prevention of rotavirus infections; clinical diagnostic testing for rotavirus; and the epidemiology and etiology of viral gastroenteritis in hospitalized children. A past president of the Pediatric Infectious Diseases Society (PIDS), Dr. Dennehy has served as a chair of the IDWeek Program Committee, as the PIDS liaison to the IDSA Board of Directors, and as the IDSA liaison for the Meningococcal Stakeholders Group at the Centers for Disease Control and Prevention. She received the PIDS Distinguished Service Award in 2012.Dr. Dennehy graduated from Radcliffe College; earned her medical degree at Tufts University School of Medicine; was an intern and resident in pediatrics at Rhode Island Hospital; and completed her fellowship in infectious diseases at a combined program of Boston Children’s Hospital, Dana Farber Cancer Center and Beth Israel Hospital.
Cynthia L. Sears, MD, FIDSA, is professor of medicine and oncology at Johns Hopkins University School of Medicine, and attending physician at Johns Hopkins Hospital. She previously was director of the Infectious Diseases Fellowship program at the university.
She serves as associate editor for Clinical Infectious Diseases and on the Editorial Advisory Board for The Journal of Infectious Diseases. Among other IDSA committees, she has served on the Program and Abstract Selection Committees, the Fellowship and Young Investigator Grants Award Committee, Training Directors Committee, Annual Meeting Program Committee, Rapid Communications Work Group, and the Board of Directors.
Dr. Sears graduated cum laude from the Thomas Jefferson School of Medicine and completed an internship and residency in internal medicine at The New York Hospital/Cornell Medical Center. She completed her fellowship in infectious diseases at the University of Virginia Medical Center.
David A. Relman, MD, FIDSA, is the Thomas C. and Joan M. Merigan Professor in the Departments of Medicine and of Microbiology and Immunology at Stanford University. Dr. Relman also serves as chief of the Infectious Diseases Section at the Veterans Affairs Palo Alto Health Care System.
Dr. Relman has played an active role in IDSA, serving on the Board of Directors, Annual Meeting Program Committee, Society Awards Committee, Scientific Advisory Committee of the Emerging Infections Network, Emerging Infections Committee, and Editor Selection Committee. He is also currently the IDSA representative to the Institute of Medicine Forum for Microbial Threats, as well as the chair of the Forum. Dr. Relman is a fellow of the American Academy of Microbiology and of the American Association for Advancement of Science, and is a member of the Association of American Physicians and the Institute of Medicine of the National Academies of Science. He graduated from Harvard Medical School, and completed his internship and residency at Massachusetts General Hospital, and then went on to Stanford University where he completed a clinical and research fellowship in infectious diseases.
The Board of Directors, 2013-2014
Barbara E. Murray, MD, FIDSA, PresidentUniversity of Texas Health Science CenterHouston, Texas
Stephen B. Calderwood, MD, FIDSA, President-ElectMassachusetts General HospitalBoston, Massachusetts
Johan S. Bakken, MD, PhD, FIDSA, Vice PresidentSt. Luke’s ID AssociatesDuluth, Minnesota
Penelope H. Dennehy, MD, FIDSA, SecretaryHasbro Children’s Hospital/Brown UniversityProvidence, Rhode Island
Cynthia L. Sears, MD, FIDSA, TreasurerJohns Hopkins University School of MedicineBaltimore, Maryland
David A. Relman, MD, FIDSA, Immediate Past PresidentStanford University School of MedicinePalo Alto, California
Barbara D. Alexander, MD, MHS, FIDSA Duke University Medical CenterDurham, NC
Upton D. Allen, MD, FIDSA Hospital for Sick ChildrenToronto, Ontario, Canada
Helen W. Boucher, MD, FIDSATufts Medical CenterBoston, Massachusetts
R. Michael Buckley, MD, FIDSAUniversity of Pennsylvania Health SystemPhiladelphia, Pennsylvania
Deborah Cotton, MD, MPH, FIDSABoston University School of MedicineBoston, Massachusetts
Stanley C. Deresinski, MD, FIDSAStanford University School of MedicineRedwood City, California
Louis B. Rice, MDWarren Alpert Medical School of Brown UniversityProvidence, Rhode Island
Steven K. Schmitt, MD, FIDSA Cleveland ClinicCleveland, Ohio
Judith A. Aberg, MD, FIDSA, HIVMA RepresentativeNew York UniversityNew York, New York
Janet A. Englund, MD, FIDSA, PIDS LiaisonSeattle Children's HospitalSeattle, Washington
Jan E. Patterson, MD, MS, FIDSA, SHEA LiaisonUniversity of Texas Health Science Center at San AntonioSan Antonio, Texas
Mark A. Leasure, Chief Executive OfficerIDSAArlington, Virginia
1300 Wilson Boulevard | Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200 | Fax: (703) 299-0204
| HIVMA | Contact Us
© Copyright IDSA 2013 Infectious Diseases Society of America